Cost-Effectiveness of Adjuvant Intravaginal Brachytherapy in High-Intermediate Risk Early Stage Endometrial Carcinoma
Stahl J, Lester-Coll N, Bledsoe T, An Y, Damast S. Cost-Effectiveness of Adjuvant Intravaginal Brachytherapy in High-Intermediate Risk Early Stage Endometrial Carcinoma. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e416. DOI: 10.1016/j.ijrobp.2017.06.1597.Peer-Reviewed Original Research